AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 281 min read$CME

SHEPARD WILLIAM R purchased $79K of CME (indirect holdings)

SHEPARD WILLIAM R purchased 293 indirectly-held shares of CME GROUP INC. (CME) at $268.76 on 2026-09-25.

Original reporting
SEC EDGAR · SHEPARD WILLIAM R
Published Sep 28, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 29, 2026, 2:46 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CME
Neutral
high confidence
Mentioned
$CME
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CMENeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to affect CME's stock price materially.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Director's indirect holdings may reflect broader confidence not captured by purchase size.

Relevance 4/10Novelty 4/10Timing: after-hours filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

Director Shepard William R purchased 293 CME shares for $78.6K, filing a Form 4 on 2026-09-25.

Expected impact

slight upward pressure as market prices in insider buying

Evidence & confidence

Purchase size is trivial relative to CME's market cap; impact limited.

Market effects

Sector

Minimal effect on financial services sector; insider activity typical.

Regional

None

Global

Low

Counterpoint

What could challenge this read

Even small insider buys can precede positive developments; monitor for upcoming guidance.

Key entities

  • Director
    Shepard William R

    Director of CME Group Inc.

  • Company
    CME Group Inc.

    Operator of global derivatives exchanges.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CME insider trading history →

Related articles

OCT 11
$CMEMed

FanDuel Gets FCM License, Raising Questions Over CME Role in Predicts

FanDuel has received a futures commission merchant (FCM) license from the National Futures Association, allowing it more control over its U.S. prediction market business. The approval raises questions about its partnership with CME Group, which holds a 51% stake in FanDuel Predicts. CME's CEO previously stated that such a license could conflict with their agreement. FanDuel's new license does not permit it to operate its own exchange, but it may seek further approvals in the future.

bonus.com2 min
OCT 8
$CMEMed

Baseball may get its first stats-based trading contracts Oct. 12, pending regulatory review.

CME Group plans to launch baseball futures on October 12, 2026, pending regulatory approval. The contracts will track CME FutureSports Performance Indexes, based on official league data of 30 professional baseball teams. Standard contracts will be valued at 10x the indexes, while micro contracts will be 1/10 their value. Trading will begin with the 2026 Postseason and the four clubs in the League Championship Series.

stocktitan.net2 min
OCT 7
$FLUTHigh

FanDuel Lands FCM License, But CME Isn’t Involved

FanDuel, owned by Flutter Entertainment (FLUT), secured a futures commission merchant (FCM) license from the National Futures Association. This approval may alter FanDuel's relationship with CME Group (CME), the majority owner of FanDuel Predicts. FanDuel has been expanding its prediction market operations, including a partnership with Crypto.com. CME has expressed concerns about FanDuel's potential competitive threat.

casino.org2 min